No Recommendation Changes after Walgreens Releases 2Q18 Results


Mar. 30 2018, Updated 9:02 a.m. ET

Walgreens in the stock market

Walgreens Boots Alliance (WBA) stock rose 3.1% after it reported better-than-expected results on March 28, 2018. The stock closed at $67.59, which was 2.5% above the previous day’s closing price.

The company’s performance has not been good so far this year. It has already lost 7% year-to-date (or YTD) and is trading 30% below its 52-week high. However, it has performed better than rivals CVS Health (CVS) and Rite Aid (RAD), which have fallen 13.5% and 15.2%, respectively, YTD.

WBA also outperformed the seven-company S&P 500 Food & Staples Retail Index, which has fallen 8.5% YTD. In comparison, the S&P 500 Index has fallen 2.6% YTD.

Article continues below advertisement

Analysts’ actions after fiscal 2Q18 results

Analysts maintained their recommendations for WBA after the fiscal 2Q18 results. However, some of them revised their price targets. Barclays increased its price target from $76 to $77, RBC Capital lowered its target price from $94 to $88, and Evercore ISI lowered its target price from $85 to $76.

WBA now has an average price target of $83.58 from 27 Wall Street analysts. The current price target indicates an upside potential of 24% over the next 12 months. In comparison, CVS Health’s share price has a stronger upside of 41%.

WBA is rated a 2.3 on a scale of 1 for “strong buy” to 5 for “sell.” About 56% of the analysts are recommending a “buy” for the stock, and 44% are recommending a “hold.” There are no “sell” recommendations.

Barclays, Morgan Stanley, and Deutsche Bank are among the brokers who are recommending a “hold” for WBA. Evercore ISI, Citigroup, and Loop Capital are recommending a “buy.”

Investors looking for exposure to WBA through ETFs can consider the Consumer Staples Select Sector SPDR ETF (XLP). WBA makes up 3.6% of XLP.


More From Market Realist

    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.